J Rhinol > Volume 22(1); 2015
Journal of Rhinology 2015;22(1):1-5.
Published online May 31, 2015.
DOI: https://doi.org/10.18787/jr.2015.22.1.1   
Development and Utilization of a Mouse Model of Nasal Polyps
Sang Wook Kim, Sea Yuong Jeon, Dae Woo Kim
1Department of Otorhinolaryngology, College of Medicine, Gyeongsang National University, Jinju, Korea. syjeon@nongae.gsnu.ac.kr
2Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju, Korea.
3Department of Otorhinolaryngology-Head and Neck Surgery, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea. kicubi@daum.net
마우스 비강 폴립 모델의 개발 및 활용
김상욱, 전시영, 김대우
경상대학교 의학전문대학원 이비인후과학교실,1 건강과학연구원,2 서울대학교 의과대학 보라매병원 이비인후과학교실3
Abstract
Systemic corticosteroids currently represent the most effective treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), but their long-term use is constrained due to their detrimental side effects. Until recently, development of novel drugs for CRSwNP has been difficult partly due to the absence of a standard animal model of CRSwNP. Exotoxins of Staphylococcus aureus such as staphylococcal enterotoxin B (SEB), are well-known superantigens which can induce a strong immune response; there have been many studies on the association of staphylococcal enterotoxins and development of CRSwNP over the past two decades. Based on previous studies, we invented a mouse model of CRSwNP using SEB. Herein, we explain the protocol development for the mouse model, as well as identify histological and immunological similarities between this mouse model and humans. Furthermore, we describe a study that analyzed the risk factors for CRSwNP such as smoking, and also elaborate on a series of studies that searched for new potential drugs for CRSwNP, including resveratrol, anti-periostin antibody, topical hypoxia-inducible factors, and topical cyclosporine. Based on preceding studies, we have concluded that this mouse model might be a useful tool to investigate the pathophysiology and development of novel drugs for CRSwNP.
Key Words: Models, animal;Mouse;Nasal polyps;Sinusitis therapeutics


TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 269 View
  • 5 Download
Related articles

Upregulation of Prostasin in Nasal Polyps2012 May;19(1)



Editorial Office
101 Hyundai ESA Apt., 20, Hyoryeong-ro 77-gil, Seocho-gu, Seoul 06628, Republic of Korea
Tel: +82-2-3461-9945    Fax: +82-2-3461-9947    E-mail: shcho@hanyang.ac.kr                

Copyright © 2021 by Korean Rhinologic Society. All rights reserved.

Developed in M2PI

Close layer
prev next